Find uplifting stories about heroes, innovations, and solutions
1232 results for "tuberculosis vaccine"
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
A groundbreaking tuberculosis vaccine currently in final trials could become the first new TB vaccine in over a century. South Africa is already preparing to roll it out if approved, potentially transforming the fight against a disease that still claims countless lives.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
Scientists in South Africa are on the brink of developing the world's first effective tuberculosis vaccine for adolescents and adults, a breakthrough that could prevent 76 million infections globally. African leaders visited the groundbreaking research site and called for urgent investment to prepare the continent for mass vaccine rollout.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
Indian researchers have validated two groundbreaking tuberculosis vaccines that show up to 79.5% effectiveness against the disease, offering new hope for children and adults in a country carrying 27% of the world's TB burden. The vaccines demonstrate particular promise in protecting kids aged 6 to 14 from all forms of TB.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Bryan Bryson is tackling tuberculosis, history's deadliest pathogen, by studying how immune cells fight back. His research could unlock the first effective TB vaccine for adults in a century. #
A 1920s tuberculosis vaccine is helping people with autoimmune diabetes reduce their insulin use in a breakthrough trial. The discovery adds to growing evidence that certain vaccines protect against diseases far beyond their original targets.
A Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. If approved, MSX-1 would be the world's first licensed bovine TB vaccine.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Showing 20 of 1232